US further restricts codeine

The US Food and Drug Administration has announced measures to limit the use of opioid-containing cough and cold preparations by children The FDA says the safety labelling changes will affect prescription opioid cough and cold medicines containing codeine or hydrocodone. The move follows efforts last year to restrict the use of codeine- or tramadol-containing OTC